Erick Lucera Dyne Therapeutics, Inc. (DYN) insider trading activity

DYN Quotes by TradingView

Erick Lucera is Chief Financial Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 66,100 shares of DYN, which is worth approximately $756,845. The most recent transaction as insider was on Mar 31, 2025, when has been sold 66,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.1K
n/a 3M change
n/a 12M change
Total Value Held $756,845

Erick Lucera Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
BUY
Grant, award, or other acquisition
-
66,100 Added 50.0%
66,100 Common Stock

Also insider at

EDIT
Editas Medicine, Inc. Healthcare
EVP, CHIEF FINANCIAL OFFICER
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
Chief Financial Officer
XAIR
Beyond Air, Inc. Healthcare
Director
SABS
SAB Biotherapeutics, Inc. Healthcare
BBLG
Bone Biologics Corp Healthcare
Director
EL

Erick Lucera

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on DYN

Follow Dyne Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

News

Receive news related to Dyne Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DYN